Vaccine Treatment for Advanced Non-Small Cell Lung Cancer

NCT00073398 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NewLink Genetics Corporation

Collaborators